• Policy
• Samil voluntarily cuts price of its Vemlino to lowest price
• by Lee, Tak-Sun Nov 19, 2024 06:13am

• Company
• Mounjaro aims for 'diabetes·obesity' synergy
• by Whang, byung-woo Nov 19, 2024 06:12am

• Company
• Academia pushes for Tagrisso’s reimbursement expansion
• by Moon, sung-ho Nov 19, 2024 06:12am

• Company
• Premium meningitis vaccine Bexsero lands in hospitals in KOR
• by Eo, Yun-Ho Nov 18, 2024 05:49am

• Company
• 'Tevimbra' can be prescribed at general hospitals
• by Eo, Yun-Ho Nov 18, 2024 05:49am

• Policy
• HK Inno.N to distribute Tamiflu as Roche’s new partner
• by Lee, Tak-Sun Nov 18, 2024 05:49am

• Company
• Demand rises for reform of the cancer drug reimb system
• by Moon, sung-ho Nov 18, 2024 05:49am

• Company
• Six reimbursement revaluations fail in 4 years
• by Chon, Seung-Hyun Nov 15, 2024 05:49am

• Policy
• AZ’s Imjudo and Imfinzi both make reimbursement progress
• by Lee, Tak-Sun Nov 15, 2024 05:49am

• Company
• Leqvio with 'twice-yearly treatment' set for mkt
• by Whang, byung-woo Nov 15, 2024 05:49am